Echo Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
Echo Therapeutics, Inc. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net of $419.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet · last filed 2015-08-14
- Echo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2015-06-30 was -$2.42M.
- Echo Therapeutics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net for the quarter ending 2015-03-31 was $2.84M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net 6 month |
|---|---|---|
| 2015-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $419.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $2.84M 10-Q · filed 2015-05-15 |